Effect of mixed tocopherols on ecNOS, SOD and PKC in leukocytes in human subjects

Nutrition Research

Volumn 22, Issue 11, 2002, Pages 1253-1263

  Liu, Meilin ^a   Wallin, Rolf ^a   Saldeen, Tom ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Endothelial constitutive nitric oxide synthase; Leukocytes; Protein kinase C; Superoxide dismutase; Tocopherols

Indexed keywords

ALPHA TOCOPHEROL; NITRIC OXIDE SYNTHASE; PROTEIN KINASE C; SUPEROXIDE DISMUTASE; TOCOPHEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENDOTHELIUM; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HEART DEATH; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LEUKOCYTE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; SHEAR STRESS; VITAMIN INTAKE;

EID: 0036846414     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0271-5317(02)00456-6     Document Type: Article

References (28)

1. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 1996;334:1156-62.
2. Yochum LA, Folsom AR, Kushi LH. Intake of antioxidant vitamins and risk of death from stroke in postmenopausal women. Am J Clin Nutr 2000;72:476-83.
3. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-6.
4. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption, and the risk of coronary disease in women. N Engl J Med 1993;328:1444-9.
5. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781-6.
6. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:154-60.
7. GISSI: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocaridal infarction: Results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999;354:447-55.
8. Collins R, Peto R, Armitage J. The MRC/BHF Heart Protection Study: Preliminary results. Int J Clin Pract 2002;56:53-6.
9. Ross R. The pathogenesis of atherosclerosis - An update. N Engl J Med 1986;314:488-500.
10. Gerrity RG. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 1981;103:181-90.
11. Devaraj S, Li D, Jialal I. The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium. J Clin Invest 1996;98:756-63.
12. Ohrvall M, Sundlof G, Vessby B. Gamma, but not alpha, tocopherol levels in serum are reduced in coronary heart disease patients. J Intern Med 1996;239:111-7.
13. Ohrvall M, Tengblad S, Vessby B. Lower tocopherol serum levels in subjects with abdominal adiposity. J Intern Med 1993;234:53-60.
14. Li D, Yang B, Mehta JL. Ox-LDL induces apoptosis in human coronary artery endothelial cells: Role of PKC, PTK, bcl-2, and Fas. Am J Physiol 1998;275:H568-76.
15. Li D, Tomson K, Yang B, Mehta P, Croker BP, Mehta JL. Modulation of constitutive nitric oxide synthase, bcl-2, and Fas expression in cultured human coronary endothelial cells exposed to anoxia-reoxygenation and angiotensin II: Role of AT1 receptor activation. Cardiovasc Res 1999;41:109-15.
16. Li D, Saldeen T, Romeo F, Mehta JL. Different isoforms of tocopherols enhance nitric oxide synthase phosphorylation and inhibit human platelet aggregation and lipid peroxidation: Implications in therapy with vitamin E. J Cardiovasc Pharmacol Ther 2001;6:155-61.
17. Institute of Medicine FaNB. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academy Press, 2000.
18. Saldeen T, Li D, Mehta JL. Differential effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis. J Am Coll Cardiol 1999;34:1208-15.
19. Fuster V. Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: Insights from studies of vascular biology. Circulation 1994;90:2126-46.
20. Kubes P, Suzuki M, Granger DN. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 1991;88:4651-5.
21. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999;399:601-5.
22. Chen ZP, Mitchelhill KI, Michell BJ, et al. AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 1999;443:285-9.
23. Hirata K-i, Kuroda R, Sakoda T, et al. Inhibition of endothelial nitric oxide synthase activity by protein kinase C. Hypertension 1995;25:180-5.
24. Inoue N, Ramasamy S, Fukai T, Nerem RM, Harrison DG. Shear stress modulates expression of Cu/Zn superoxide dismutase in human aortic endothelial cells. Circ Res 1996;79:32-7.
25. Gryglewski RJ, Palmer RM, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986;320:454-6.
26. Li Q, Cathcart MK. Protein kinase C activity is required for lipid oxidation of low density lipoprotein by activated human monocytes. J Biol Chem 1994;269:17508-15.
27. Keaney JF, Guo Y, Cunningham D, Shwaery GT, Xu A, Vita JA. Vascular incorporation of alphatocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. J Clin Invest 1996;98:386-94.
28. Ricciarelli R, Tasinato A, Clement S, Ozer NK, Boscoboinik D, Azzi A. Alpha-Tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochem J 1998;334:243-9.